• Develop your
    business right
    WAY
    Well Qualified and Experienced Scientists to Serve
    Your Drug Discovery Needs.
  • Develop your
    business right
    WAY
    Your Reliable Partner in Process Development.
  • Develop your
    business right
    WAY
    Innovative Centre for Impurity Synthesis,
    Isolation and Qualification.
  • Develop your
    business right
    WAY
    Destination for Custom Synthesis Projects.
Scinva is an innovation driven chemical synthesis company holding expertise in manufacturing
chemicals that have various applications. We have emerged as leading custom chemical synthesis
services providers.
 Click to contacts!

Our Services

  • Custom Synthesis

  • Literature scouting, scheme optimization and skill to carry out multi-step synthesis.
  • Read more...
  • Impurity Profiling

  • Scinva supports your product development and audit situations by providing wide range.
  • Read more...
  • Drug Discovery

  • Intuition of medicinal chemist is greatest source of drug discovery, Scinva has required.
  • Read more...
  • Process Development

  • Team Scinva has acquired thorough proficiency in process development by implementing several.
  • Read more...

Latest News

  • Next generation cardiovascular drugs
  • 23 Jun | scinvapharma
  • Thanks To Genomic Sequencing, Some Heart-healthy Mutants And Billions Of Dollars Spent On R&D, Rival Drug Developers Are Bearing Down On A Promising New Way Of Treating The Scourge Of High Cholesterol. And With The First FDA Applications Likely Coming In The Next Year, The Nascent Field's Trailblazers Are Vying For The Top Spot With Blockbuster Aspirations.

    & ....
  • Read more
  • Money churning drugs of 2014
  • 24 Apr | scinvapharma
  • Gilead's Drug Sovaldi For Hepatitis C Virus, GlaxoSmithKline/Theravance's Anoro Ellipta For Chronic Obstructive Pulmonary Disease (COPD), And Gilead's Idelalisib For Indolent Non-Hodgkin's Lymphoma Are The Leading Drugs To Watch In 2014, According To A Report By Thomson Reuters. The Three Potential Blockbuster Treatments Are Anticipated To Gain More Than ....

  • Read more
  • New Anticancer Target Identified
  • 24 Apr | scinvapharma
  • In Two New Papers, Researchers Confirm Earlier Hints That An Enzyme Called MTH1 Is Critical For Cancer Cell Proliferation. They Identified Inhibitors Of The Enzyme And Showed That The Compounds Suppress Tumor Growth In Cancerous Mice. In Addition, They Found That An Anticancer Agent Of Previously Unknown Mechanism Works By Inhibiting MTH1 And Also Identified Another Inhibitor With Bett ....

  • Read more
  • Innocentive challenge success
  • 06 May | scinvapharma
  • We Are Glad To Announce That Scinva’s Target Focused Library Has Been Chosen For Synthesis And Evaluation By Innocentive Challenge, Which Is Worldwide Crowd Sourcing Competition. The Success Is Testimony For Our World Class Capability In Designing Novel Molecules To Modulate Therapeutic Targets. 

    ....
  • Read more

Featured Products

Send an Enquiry